BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31115783)

  • 1. Prevalence and clinical presentation of cirrhotic cardiomyopathy: A single centre experience from southern India.
    Bokarvadia R; Jain M; Kedarisetty C; Varghese J; Venkataraman J
    Indian J Gastroenterol; 2019 Apr; 38(2):150-157. PubMed ID: 31115783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.
    Shukla A; Bhatt P; Gupta DK; Modi T; Patel J; Phadke M; Rathod K; Meshram M; Bhatia SJ
    Indian J Gastroenterol; 2017 Nov; 36(6):474-480. PubMed ID: 29368192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cirrhotic cardiomyopathy and its relationship with serum pro-brain natriuretic peptide, hepatorenal syndrome, spontaneous bacterial peritonitis, and mortality.
    Kapoor N; Mehta V; Singh B; Karna R; Kumar S; Kar P
    Indian J Gastroenterol; 2020 Oct; 39(5):481-486. PubMed ID: 33188455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for cirrhotic cardiomyopathy: a prospective cross-sectional study.
    Xu H; Zhang Y; Gao Y
    Eur J Gastroenterol Hepatol; 2024 Apr; 36(4):469-475. PubMed ID: 38407871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria.
    Izzy M; Soldatova A; Sun X; Angirekula M; Mara K; Lin G; Watt KD
    Liver Transpl; 2021 Jun; 27(6):876-886. PubMed ID: 33533556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric cirrhotic cardiomyopathy: Impact on liver transplant outcomes.
    Junge N; Junge C; Schröder J; Pfister ED; Leiskau C; Hohmann D; Beerbaum P; Baumann U
    Liver Transpl; 2018 Jun; 24(6):820-830. PubMed ID: 29637720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis.
    Kim MY; Baik SK; Won CS; Park HJ; Jeon HK; Hong HI; Kim JW; Kim HS; Kwon SO; Kim JY; Yoo BS; Lee SH
    Korean J Hepatol; 2010 Dec; 16(4):376-82. PubMed ID: 21415581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Prevalence of Cirrhotic Cardiomyopathy: A Systematic Review and Meta-analysis.
    Shahvaran SA; Menyhárt O; Csedrik L; Patai ÁV
    Curr Probl Cardiol; 2021 Oct; 46(10):100821. PubMed ID: 34016482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival.
    Huang CH; Wu LS; Jeng WJ; Cheng YF; Ko YS; Sheen IS; Lin CY
    PLoS One; 2019; 14(3):e0212770. PubMed ID: 30889181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of cardiomyopathy in children with cirrhotic and noncirrhotic portal hypertension.
    Celtik C; Durmaz O; Oner N; Yavuz T; Gökce S; Aydogan A; Nisli K; Emiroglu HH; Ömeroglu RE; Sökücü S
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):177-81. PubMed ID: 25250684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy.
    Abbas WA; Kasem Ahmed SM; Abdel Aal AM; Mahmoud AA; Abdelmalek MO; Mekky MA; Abozaid MA; Ibrahim AK
    Turk J Gastroenterol; 2016 Jul; 27(4):367-74. PubMed ID: 27458853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Study of Prevalence and Predictors of Cirrhotic Cardiomyopathy and Its Role in Development of Hepatorenal Syndrome.
    Anikhindi SA; Ranjan P; Kumar M; Mohan R
    J Clin Exp Hepatol; 2022; 12(3):853-860. PubMed ID: 35677509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and persistence of cirrhotic cardiomyopathy after liver transplantation.
    Sonny A; Ibrahim A; Schuster A; Jaber WA; Cywinski JB
    Clin Transplant; 2016 Sep; 30(9):986-93. PubMed ID: 27292629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?
    Barbosa M; Guardado J; Marinho C; Rosa B; Quelhas I; Lourenço A; Cotter J
    World J Hepatol; 2016 Jan; 8(3):200-6. PubMed ID: 26839643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.
    Koshy AN; Gow PJ; Testro A; Teh AW; Ko J; Lim HS; Han HC; Weinberg L; VanWagner LB; Farouque O
    Am J Transplant; 2021 Jun; 21(6):2240-2245. PubMed ID: 33453141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the 2005 Montreal Criteria and the 2019 Cirrhotic Cardiomyopathy Consortium Criteria for the Diagnosis of Cirrhotic Cardiomyopathy.
    Luo Y; Yin S; Chen Q; Liu J; Chong Y; Zhong J
    Am J Cardiol; 2023 Dec; 208():180-189. PubMed ID: 37852128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhotic cardiomyopathy.
    Elleuch N; Mrabet S; Ben Slama A; Jaziri H; Hammami A; Brahim A; Ajmi S; Ksiaa M; Jmaa A
    Tunis Med; 2020 Mar; 98(3):206-210. PubMed ID: 32395813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirrhotic cardiomyopathy: a cardiologist's perspective.
    Gassanov N; Caglayan E; Semmo N; Massenkeil G; Er F
    World J Gastroenterol; 2014 Nov; 20(42):15492-8. PubMed ID: 25400434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
    Singh AD; Ford A; Lyu R; Layoun H; Harb SC; Fares M; Carey WD
    Dig Dis Sci; 2022 Nov; 67(11):5315-5326. PubMed ID: 35150344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Cardiac Dysfunction in Portal Hypertension: A Single-Center Experience From Eastern India.
    Behera SK; Behera P; Behera JR; Behera G
    Cureus; 2023 Dec; 15(12):e51259. PubMed ID: 38283536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.